Lupus Clinical Trials in Chicago

Showing 201-220 of 248 trials

Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus

NCT01709474

The primary objective of this study is to evaluate the effects of 18 weeks of high-dose vitamin D3 supplementation compared with standard-dose vitamin D3 supplementation on immune function, glucose homeostasis, and bone metabolism in children with systemic lupus erythematosus (SLE) and serum 25-hydroxyvitamin D \[25(OH)D\] levels ≤20 ng/mL.

Systemic Lupus Erythematosus

National Institute of Allergy and Infectious Diseases (NIAID)7 participantsStarted Jun 2013

Los Angeles, California, United States • Palo Alto, California, United States • San Francisco, California, United States +10 more locations

COMPLETEDNA2.2 miles

Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk

NCT01156116

Although obstructive sleep apnea (OSA) is associated with impaired glucose tolerance and diabetes, it remains unclear whether OSA treatment with continuous positive airway pressure (CPAP) has metabolic benefits. The objective of this study is to determine the effect of 8-hour nightly CPAP treatment on glucose metabolism in individuals with prediabetes and OSA.

DiabetesSleep Apnea

University of Chicago39 participantsStarted Oct 2009

Chicago, Illinois, United States

Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus

Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk

Lupus Trials in Other Cities

Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome

Study of Epratuzumab in Systemic Lupus Erythematosus

PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Incidence of Obstructive Sleep Apnea in Pregnancy

A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age

A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus

PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus

A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321

Childhood Adenotonsillectomy Study for Children With OSAS

A Multi-Center Study to Assess the Performance of Saturation Patterns.

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea

Understanding Sleep Problems in Children With Autism Spectrum Disorder

Electrical Status Epilepticus in Sleep: Response of Neuropsychological Deficits and Epileptiform Activity to Clobazam Treatment

Other Conditions in Chicago